v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Class A
Common Class B
Common Stock
Common Class A
Common Stock
Common Class B
Additional Paid-in Capital
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021 [1]       4,668,678 134,839      
Beginning balance at Dec. 31, 2021 $ 652,205     $ 47 [1] $ 1 [1] $ 1,672,588 $ (1,020,142) $ (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (11,073)           (11,073)  
Compensation expense related to granting of stock awards (in shares) [1]       (1,978)        
Compensation expense related to granting of stock awards 2,698         2,698    
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares) [1]       2,034        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 177         177    
Purchase of vested employee restricted stock units (in shares) [1]       (20,729)        
Purchase of vested employee restricted stock units (1,839)         (1,839)    
Payment of dividends on common stock (174)         (174) 0  
Dividend equivalents, net of forfeitures 202           202 0
Net unrealized gain (loss) on derivatives 1,223           0 1,223
Ending balance (in shares) at Mar. 31, 2022 [1]       4,648,005 134,839      
Ending balance at Mar. 31, 2022 643,419     $ 47 [1] $ 1 [1] 1,673,450 (1,031,013) 934
Beginning balance (in shares) at Dec. 31, 2021 [1]       4,668,678 134,839      
Beginning balance at Dec. 31, 2021 652,205     $ 47 [1] $ 1 [1] 1,672,588 (1,020,142) (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (152,821)              
Net unrealized gain (loss) on derivatives 3,198              
Ending balance (in shares) at Sep. 30, 2022 [1]       4,710,739 134,839      
Ending balance at Sep. 30, 2022 507,011     $ 48 [1] $ 1 [1] 1,676,808 (1,172,755) 2,909
Beginning balance (in shares) at Mar. 31, 2022 [1]       4,648,005 134,839      
Beginning balance at Mar. 31, 2022 643,419     $ 47 [1] $ 1 [1] 1,673,450 (1,031,013) 934
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (773)           (773)  
Compensation expense related to granting of stock awards (in shares) [1]       57,934        
Compensation expense related to granting of stock awards 2,481     $ 1 [1]   2,480    
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares) [1]       4,706        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 132         132    
Purchase of vested employee restricted stock units (in shares) [1]       (760)        
Purchase of vested employee restricted stock units (51)         (51)    
Payment of dividends on common stock (4)         (4)    
Dividend equivalents, net of forfeitures 4           4  
Net unrealized gain (loss) on derivatives 553             553
Ending balance (in shares) at Jun. 30, 2022 [1]       4,709,885 134,839      
Ending balance at Jun. 30, 2022 645,761     $ 48 [1] $ 1 [1] 1,676,007 (1,031,782) 1,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (140,975)           (140,975)  
Compensation expense related to granting of stock awards (in shares) [1]       (5,606)        
Compensation expense related to granting of stock awards 726     $ 0 [1]   726    
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares) [1]       6,606        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 77         77    
Purchase of vested employee restricted stock units (in shares) [1]       (146)        
Purchase of vested employee restricted stock units (2)         (2)    
Dividend equivalents, net of forfeitures 2         2    
Net unrealized gain (loss) on derivatives 1,422             1,422
Ending balance (in shares) at Sep. 30, 2022 [1]       4,710,739 134,839      
Ending balance at Sep. 30, 2022 507,011     $ 48 [1] $ 1 [1] 1,676,808 (1,172,755) 2,909
Beginning balance (in shares) at Dec. 31, 2022   4,705,328 134,839 4,705,328 [2] 134,839 [2]      
Beginning balance at Dec. 31, 2022 520,619     $ 47 [2] $ 1 [2] 1,678,247 (1,160,618) 2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (35,901)           (35,901)  
Compensation expense related to granting of stock awards (in shares) [2]       195,724        
Compensation expense related to granting of stock awards 1,949     $ 2 [2]   1,947    
Purchase of vested employee restricted stock units (in shares) [2]       (27,072)        
Purchase of vested employee restricted stock units (127)         (127)    
Payment of dividends on common stock (60)         (60)    
Dividend equivalents, net of forfeitures 22           22  
Net unrealized gain (loss) on derivatives (840)             (840)
Ending balance (in shares) at Mar. 31, 2023 [2]       4,873,980 134,839      
Ending balance at Mar. 31, 2023 485,662     $ 49 [2] $ 1 [2] 1,680,007 (1,196,497) 2,102
Beginning balance (in shares) at Dec. 31, 2022   4,705,328 134,839 4,705,328 [2] 134,839 [2]      
Beginning balance at Dec. 31, 2022 520,619     $ 47 [2] $ 1 [2] 1,678,247 (1,160,618) 2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss $ (396,036)              
Repurchase of common stock (in shares) 0              
Net unrealized gain (loss) on derivatives $ (1,598)              
Ending balance (in shares) at Sep. 30, 2023   4,866,563 134,839 4,866,563 [2] 134,839 [2]      
Ending balance at Sep. 30, 2023 126,623     $ 49 [2] $ 1 [2] 1,681,823 (1,556,594) 1,344
Beginning balance (in shares) at Mar. 31, 2023 [2]       4,873,980 134,839      
Beginning balance at Mar. 31, 2023 485,662     $ 49 [2] $ 1 [2] 1,680,007 (1,196,497) 2,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (125,802)           (125,802)  
Compensation expense related to granting of stock awards (in shares) [2]       (7,449)        
Compensation expense related to granting of stock awards 1,049         1,049    
Repurchase of common stock (in shares) [2]       (215)        
Repurchase of common stock (1)         (1)    
Purchase of vested employee restricted stock units (in shares) [2]       (557)        
Purchase of vested employee restricted stock units (2)         (2)    
Payment of dividends on common stock 21         21    
Dividend equivalents, net of forfeitures 38           38  
Net unrealized gain (loss) on derivatives (391)             (391)
Ending balance (in shares) at Jun. 30, 2023 [2]       4,865,759 134,839      
Ending balance at Jun. 30, 2023 360,574     $ 49 [2] $ 1 [2] 1,681,074 (1,322,261) 1,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (234,333)           (234,333)  
Compensation expense related to granting of stock awards (in shares) [2]       950        
Compensation expense related to granting of stock awards 749         749    
Purchase of vested employee restricted stock units (in shares) [2]       (146)        
Purchase of vested employee restricted stock units 0              
Net unrealized gain (loss) on derivatives (367)             (367)
Ending balance (in shares) at Sep. 30, 2023   4,866,563 134,839 4,866,563 [2] 134,839 [2]      
Ending balance at Sep. 30, 2023 $ 126,623     $ 49 [2] $ 1 [2] $ 1,681,823 $ (1,556,594) $ 1,344
[1] (1) Share counts have been retroactively adjusted to reflect the effect of the reverse stock split.
[2] (1) Share counts have been retroactively adjusted to reflect the effect of the reverse stock split.